20
Apotex Pharmachem Inc, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DARIFENACIN HYDROBROMIDE, with a corresponding US DMF Number 26824.
Remarkably, this DMF maintains an Active status since its submission on August 23, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 14, 2014, and payment made on March 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II